Ligand inhibition studies on the role of Fc receptors in antibody-dependent cell-mediated cytotoxicity.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Molecular Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0161-5890(84)90088-9PMID 6608661
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The use of synthetic gamma-chain peptides in the localization of the binding site(s) on human IgG1 for the Fc receptors of homologous monocytes and heterologous mouse macrophages.

  1982cited by this paper
• The Fc receptor model of membrane cytoplasmic signalling.

  1982cited by this paper
• Tapping the immunological repertoire to produce antibodies of predetermined specificity

  1982cited by this paper
• The influence of tissue transglutaminase on the function of Fc receptors.

  1982cited by this paper
• Application of synthetic peptides representative of immunoglobulin sequences to the delineation of receptor binding and signalling processes.

  1982cited by this paper
• Functional affinity constants of subfragments of immunoglobulin G for Clq.

  1982cited by this paper
• Tuftsin: a naturally occurring immunopotentiating factor. I. In vitro enhancement of murine natural cell-mediated cytotoxicity.

  1981cited by this paper
• Interaction between actomyosin complexes and Fc receptors on human peripheral mononuclear blood cells

  1981cited by this paper
• Inhibition of C1-mediated immune hemolysis by monomeric and dimeric peptides from the second constant domain of human immunoglobulin G.

  1981cited by this paper
• Structure and function of immunoglobulin domains. VIII. An analysis of the structural requirements in human IgG1 for binding to the Fc receptor of human monocytes.

  1980cited by this paper
• Antibody‐dependent, cell‐mediated cytotoxicity against human red blood cells: correlation of effector cell type with enzymatic alteration of the target cell surface

  1980cited by this paper
• Correlation between effector lymphocytes in natural and antibody-mediated cytotoxicity.

  1979cited by this paper
• The heterogeneity of Fc receptors on human peripheral mononuclear blood cells.

  1979cited by this paper
• An IgG primary sequence exposure theory for complement activation using synthetic peptides

  1979cited by this paper
• Interactions of radiolabeled tuftsin with human neutrophils.

  1978cited by this paper
• Shedding and reappearance of Fc, C3 and SRBC receptors on peripheral lymphocytes from normal donors and chronic lymphatic leukaemia (CLL) patients.

  1978cited by this paper
• Isolation and characterization of Fc-receptors shed from human peripheral mononuclear cells.

  1978cited by this paper
• Binding site of human IgG subclasses and their domains for Fc receptors of activated murine T cells.

  1977cited by this paper
• Separation and properties of EA‐rosette‐forming lymphocytes in humans

  1977cited by this paper
• Structure and function of immunoglobulin domains. III. Isolation and characterization of a fragment corresponding to the Cgamma2 homology region of human immunoglobin G1.

  1976cited by this paper
• Conformational isomerism, rotational allomerism, and divergent evolution in immunoglobulin light chains.

  1976cited by this paper
• Interaction of K lymphocytes with myeloma proteins of different IgG subclasses.

  1976cited by this paper
• Localization of the IgG effector site for monocyte receptors.

  1975cited by this paper
• Structural Requirements in the Fc Region of Rabbit IgG Antibodies Necessary to Induce Cytotoxicity by Human Lymphocytes

  1975cited by this paper
• Effector activating determinants on IgG. II. Differentiation of the combining sites for C1q from those for cytotoxic K cells and neutrophils by plasmin digestion of rabbits IgG.

  1974cited by this paper
• Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies.

  1971cited by this paper
• C1q: Rapid Purification Method for Preparation of Monospecific Antisera and for Biochemical Studies

  1971cited by this paper
• Separation of leukocytes from blood and bone marrow. Introduction.

  1968cited by this paper
• Separation of leukocytes from blood and bone marrow. Introduction.

  1968cited by this paper
• Solid phase peptide synthesis. I. the synthesis of a tetrapeptide

  1963cited by this paper

• Functional mapping of the Fc gamma RII binding site on human IgG1 by synthetic peptides.

  2004cites this paper
• Functional mapping of the FcγRII binding site on human IgG1 by synthetic peptides

  2004cites this paper
• High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR*

  2001cites this paper
• Fcγ Receptors in Malignancies: Friends or Enemies?

  1994cites this paper
• Fc gamma receptors in malignancies: friends or enemies?

  1994cites this paper
• Routine preparation of thiol oligonucleotides: application to the synthesis of oligonucleotide-peptide hybrids.

  1994cites this paper
• Regulation of antibody production mediated by Fc gamma receptors, IgG binding factors, and IgG Fc-binding autoantibodies.

  1992cites this paper
• Effect of human IgG1 peptides on the antigen-specific antibody response of mice in vivo.

  1992cites this paper
• Mapping and comparison of the interaction sites on the Fc region of IgG responsible for triggering antibody dependent cellular cytotoxicity (ADCC) through different types of human Fc gamma receptor.

  1992cites this paper
• Prognostic significance of the heterogenous expression of IgG Fc receptors in B-cell chronic lymphocytic leukemia

  1992cites this paper
• Synthetic peptides comprising defined sequences of CH-2 and CH-3 domains of human IgG1 induce prostaglandin E2 production from human peripheral blood mononuclear cells.

  1992cites this paper
• Modulation of type II Fc gamma receptor expression on activated human B lymphocytes.

  1991cites this paper
• Modulatory effect of synthetic human IgG Fc peptides on the in vitro immune response of murine spleen cells.

  1991cites this paper
• Functional interactions of aglycosylated monoclonal anti-D with Fc gamma RI+ and Fc gamma RIII+ cells.

  1991cites this paper
• Modulation of type II Fcγ receptor expression on activated human B lymphocytes

  1991cites this paper
• The two binding‐site models of human IgG binding Fcγ receptors

  1990cites this paper
• 8 – The ability of IgG subclasses to cause the elimination of targets in vivo and to mediate their destruction by phagocytosis/cytolysis in vitro

  1990cites this paper
• CHAPTER 29 – Bacterial Fc receptors as putative virulence factors

  1990cites this paper
• Fcγ RII expression and release on resting and activated human B lymphocytes

  1990cites this paper
• Fc gamma RII expression and release on resting and activated human B lymphocytes.

  1990cites this paper
• Heterogeneity in the ability of IgG1 monoclonal anti‐D to promote lymphocyte‐mediated red cell lysis

  1989cites this paper
• Quantitative binding of Fc-receptors, and antibody-dependent cell-mediated cytotoxicity of blood lymphocytes in healthy and chronic lymphocytic leukemic cattle.

  1989cites this paper
• IgG-Fc-receptors: ligand binding and lysis induction.

  1989cites this paper
• Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions.

  1989cites this paper
• Quantitative binding of Fc-receptors, and antibody-dependent cell-mediated cytotoxicity of blood lymphocytes in healthy and chronic lymphocytic leukemic cattle

  1989cites this paper
• The effect of synthetic peptides corresponding to Fc sequences in human IgG 1 on various steps in the B cell activation pathway

  1988cites this paper
• [Quantitative parameters of the IgG binding by Fc receptors and the functional activity of blood lymphocytes in healthy cattle and cattle with chronic lympholeukemia].

  1988cites this paper
• Immunomodulatory effect of synthetic peptides corresponding to sequences within the CH2 and CH3 domain of human IgG1.

  1988cites this paper
• K-cell-mediated cytotoxicity induced with rat monoclonal antibodies. I. Antibodies of various isotypes differ in their ability to induce cytotoxicity mediated by rat and human effectors.

  1988cites this paper
• Inhibition of binding of rat IgE to rat mast cells by synthetic IgE peptides

  1987cites this paper
• Receptors and Other Targets for Toxic Substances

  1986cites this paper
• Binding characteristics and isotype specificity of Fc receptors on K cells.

  1986cites this paper
• The use of synthetic peptides in the delineation of immunoglobulin antigenic epitopes and Fc effector functions.

  1986cites this paper
• CH2 and CH3 domain deleted IgG1 paraproteins inhibit differently Fc receptor mediated binding and cytolysis.

  1986cites this paper
• Fc receptors on mouse neutrophils and eosinophils: antigenic characteristics, isotype specificity and relative cell membrane density measured by flow cytometry.

  1985cites this paper
• The role of immunoreceptors.

  1985cites this paper
• Reversal of antibody-dependent cellular cytotoxicity suppression by cycloheximide.

  1985cites this paper
• Mapping the functional topography of Fcγ with monoclonal antibodies: localization of epitopes interacting with the binding sites of Fc receptor on human K cells

  1985cites this paper
• Receptor conversion: One possible pathway in Fc-receptor-mediated regulation

  1985cites this paper
• Isolation of labile Fcgamma-receptors from human peripheral blood lymphocytes and production of an antiserum.

  1985cites this paper
• Fc receptors on lymphocytes and K cells.

  1984cites this paper
• Use of synthetic peptides with immunoglobulin-heavy-chain sequences in the delineation of Fc effector function.

  1984cites this paper